{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:13:39Z","timestamp":1778105619459,"version":"3.51.4"},"reference-count":0,"publisher":"Association of Basic Medical Sciences of FBIH","issue":"9","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomol Biomed"],"abstract":"<jats:p>Lysosomal-associated protein transmembrane (LAPTM) family members\u2014LAPTM4A, LAPTM4B, and LAPTM5\u2014regulate lysosomal integrity, autophagy\u2013lysosome flux, lipid homeostasis, and immune signaling, pathways increasingly implicated in neurological disease. This review synthesizes structure\u2013function evidence for LAPTM proteins and examines how their dysregulation contributes to Alzheimer\u2019s and Parkinson\u2019s disease, ischemia\u2013reperfusion injury, and gliomas. Based on a targeted narrative analysis of primary and translational studies, we highlight that LAPTM proteins influence lysosomal acidification and membrane stability, endolysosomal trafficking, and ceramide\/ion handling, thereby shaping protein aggregate clearance, oxidative stress responses, and microglia\/macrophage polarization. Preclinical data link LAPTM5 to stroke outcomes via stress-kinase and lysosomal pathways, while LAPTM4A and LAPTM4B associate with glioma progression, immune evasion, and therapy resistance. Overall, LAPTM proteins represent promising biomarkers and therapeutic targets, warranting cell-type-resolved validation and central nervous system\u00a0(CNS)-optimized delivery strategies, including gene therapy, small-molecule\/degrader approaches, and multi-omics-guided patient stratification.<\/jats:p>","DOI":"10.17305\/bb.2026.13624","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:25:43Z","timestamp":1770744343000},"page":"1426-1441","source":"Crossref","is-referenced-by-count":0,"title":["LAPTM proteins in neurological disorders \u2013 Autophagy\u2013lysosome dysfunction and therapeutic targets: A review"],"prefix":"10.17305","volume":"26","author":[{"given":"Bowen","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6922","published-online":{"date-parts":[[2026,2,10]]},"container-title":["Biomolecules and Biomedicine"],"original-title":[],"link":[{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/download\/13624\/4126","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/download\/13624\/4126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:01:06Z","timestamp":1778104866000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/view\/13624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":0,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.17305\/bb.2026.13624","relation":{},"ISSN":["2831-090X","2831-0896"],"issn-type":[{"value":"2831-090X","type":"electronic"},{"value":"2831-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}